LMAT logo

LMAT
Lemaitre Vascular Inc

522
Mkt Cap
$2.62B
Volume
123,306.00
52W High
$115.33
52W Low
$78.01
PE Ratio
45.81
LMAT Fundamentals
Price
$117.67
Prev Close
$115.17
Open
$115.64
50D MA
$101.94
Beta
0.73
Avg. Volume
273,774.25
EPS (Annual)
$2.52
P/B
6.66
Rev/Employee
$381,071.76
$1,686.01
Loading...
Loading...
News
all
press releases
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High - What's Next?
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 52-Week High - Here's What Happened...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Acquired by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL purchased a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 69,202 shares of the medical instruments supplier's stock, valu...
MarketBeat·6d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital
Freedom Capital raised LeMaitre Vascular to a "hold" rating in a report on Tuesday...
MarketBeat·12d ago
News Placeholder
SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT
SG Americas Securities LLC lifted its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 343.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 55,809 shares of the medical instruments supplier's sto...
MarketBeat·12d ago
News Placeholder
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.
Zacks·14d ago
News Placeholder
JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT
JPMorgan Chase & Co. cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 18.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·16d ago
News Placeholder
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat...
MarketBeat·16d ago
News Placeholder
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K
Key Points2,625 shares were exercised and sold on March 11, 2026, generating a transaction value of approximately $285,000 at a weighted average sale price of around $108.50 per share...
Nasdaq News: Markets·17d ago
News Placeholder
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know
Key PointsAn executive of LeMaitre Vascular reported selling 2,625 shares of the company for $285,000 on March 11, 2026...
Nasdaq News: Markets·18d ago
News Placeholder
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Bought by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL bought a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·20d ago
<
1
2
...
>

Latest LMAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.